-
1
-
-
4344574336
-
Pharmacogenetics - Five decades of therapeutic lessons from genetic diversity
-
Meyer U.A. Pharmacogenetics - Five decades of therapeutic lessons from genetic diversity. Nat. Rev. Genet. 2004, 5:669-676.
-
(2004)
Nat. Rev. Genet.
, vol.5
, pp. 669-676
-
-
Meyer, U.A.1
-
2
-
-
14344258388
-
Pharmacogenetics and geographical ancestry: implications for drug development and global health
-
Daar A.S., Singer P.A. Pharmacogenetics and geographical ancestry: implications for drug development and global health. Nat. Rev. Genet. 2005, 6:241-246.
-
(2005)
Nat. Rev. Genet.
, vol.6
, pp. 241-246
-
-
Daar, A.S.1
Singer, P.A.2
-
3
-
-
34447122644
-
Pharmacogenomics: challenges and opportunities
-
Roden D.M., et al. Pharmacogenomics: challenges and opportunities. Ann. Intern. Med. 2006, 145:749-757.
-
(2006)
Ann. Intern. Med.
, vol.145
, pp. 749-757
-
-
Roden, D.M.1
-
4
-
-
52149099016
-
Disability and genetics in the era of genomic medicine
-
Scully J.L. Disability and genetics in the era of genomic medicine. Nat. Rev. Genet. 2008, 9:797-802.
-
(2008)
Nat. Rev. Genet.
, vol.9
, pp. 797-802
-
-
Scully, J.L.1
-
5
-
-
55449120805
-
Genetic mapping in human disease
-
Altshuler D., et al. Genetic mapping in human disease. Science 2008, 322:881-888.
-
(2008)
Science
, vol.322
, pp. 881-888
-
-
Altshuler, D.1
-
6
-
-
58149328829
-
Metabolic and cardiovascular traits: an abundance of recently identified common genetic variants
-
Mohlke K.L., et al. Metabolic and cardiovascular traits: an abundance of recently identified common genetic variants. Hum. Mol. Genet. 2008, 17:R102-R108.
-
(2008)
Hum. Mol. Genet.
, vol.17
-
-
Mohlke, K.L.1
-
7
-
-
44349167229
-
Multiple genetic loci for bone mineral density and fractures
-
Styrkarsdottir U., et al. Multiple genetic loci for bone mineral density and fractures. N. Engl. J. Med. 2008, 358:2355-2365.
-
(2008)
N. Engl. J. Med.
, vol.358
, pp. 2355-2365
-
-
Styrkarsdottir, U.1
-
8
-
-
0032974197
-
Modeling of pharmacokinetic/pharmacodynamic (PK/PD) relationships: concepts and perspectives
-
Derendorf H., Meibohm B. Modeling of pharmacokinetic/pharmacodynamic (PK/PD) relationships: concepts and perspectives. Pharm. Res. 1999, 16:176-185.
-
(1999)
Pharm. Res.
, vol.16
, pp. 176-185
-
-
Derendorf, H.1
Meibohm, B.2
-
9
-
-
0028874048
-
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
-
Ho D.D., et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995, 373:123-126.
-
(1995)
Nature
, vol.373
, pp. 123-126
-
-
Ho, D.D.1
-
10
-
-
0029967721
-
HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time
-
Perelson A.S., et al. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 1996, 271:1582-1586.
-
(1996)
Science
, vol.271
, pp. 1582-1586
-
-
Perelson, A.S.1
-
11
-
-
18844452358
-
Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update
-
Mouton J.W., et al. Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update. J. Antimicrob. Chemother. 2005, 55:601-607.
-
(2005)
J. Antimicrob. Chemother.
, vol.55
, pp. 601-607
-
-
Mouton, J.W.1
-
12
-
-
0036671301
-
Functional mapping of quantitative trait loci underlying the character process: a theoretical framework
-
Ma C.-X., et al. Functional mapping of quantitative trait loci underlying the character process: a theoretical framework. Genetics 2002, 161:1751-1762.
-
(2002)
Genetics
, vol.161
, pp. 1751-1762
-
-
Ma, C.-X.1
-
13
-
-
1942530537
-
Functional mapping of quantitative trait loci underlying growth trajectories using a transform-both-sides logistic model
-
Wu R., et al. Functional mapping of quantitative trait loci underlying growth trajectories using a transform-both-sides logistic model. Biometrics 2004, 60:729-738.
-
(2004)
Biometrics
, vol.60
, pp. 729-738
-
-
Wu, R.1
-
14
-
-
33644845428
-
Functional mapping - how to map and study the genetic architecture of dynamic complex traits
-
Wu R.L., Lin M. Functional mapping - how to map and study the genetic architecture of dynamic complex traits. Nat. Rev. Genet. 2006, 7:229-237.
-
(2006)
Nat. Rev. Genet.
, vol.7
, pp. 229-237
-
-
Wu, R.L.1
Lin, M.2
-
15
-
-
33646111432
-
Visualizing gene determinants of disease in drug discovery
-
Delrieu O., Bowman C. Visualizing gene determinants of disease in drug discovery. Pharmacogenomics 2006, 7:311-329.
-
(2006)
Pharmacogenomics
, vol.7
, pp. 311-329
-
-
Delrieu, O.1
Bowman, C.2
-
16
-
-
65849431826
-
Joint functional mapping of quantitative trait loci for HIV-1 and CD4+ dynamics
-
5, Article 9
-
Wang, Z. et al. (2009) Joint functional mapping of quantitative trait loci for HIV-1 and CD4+ dynamics. Int. J. Biostat. 5, Article 9.
-
(2009)
Int. J. Biostat.
-
-
Wang, Z.1
-
17
-
-
0032967837
-
Population HIV-1 dynamics in vivo: applicable models and inferential tools for virological data from AIDS clinical trials
-
Wu H., Ding A.A. Population HIV-1 dynamics in vivo: applicable models and inferential tools for virological data from AIDS clinical trials. Biometrics 1999, 55:410-418.
-
(1999)
Biometrics
, vol.55
, pp. 410-418
-
-
Wu, H.1
Ding, A.A.2
-
18
-
-
17344364659
-
Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy
-
Marschner I.C., et al. Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy. J. Infect. Dis. 1998, 177:40-47.
-
(1998)
J. Infect. Dis.
, vol.177
, pp. 40-47
-
-
Marschner, I.C.1
-
19
-
-
0036970596
-
A joint model for nonlinear mixed-effects models with censoring and covariates measured with error, with application to AIDS studies
-
Wu L. A joint model for nonlinear mixed-effects models with censoring and covariates measured with error, with application to AIDS studies. J. Am. Stat. Assoc. 2002, 97:955-964.
-
(2002)
J. Am. Stat. Assoc.
, vol.97
, pp. 955-964
-
-
Wu, L.1
-
20
-
-
46049115677
-
Modeling the genetic control of HIV-1 dynamics after highly active antiretroviral therapy
-
Ma C.-X., et al. Modeling the genetic control of HIV-1 dynamics after highly active antiretroviral therapy. Curr. Genomics 2008, 9:208-211.
-
(2008)
Curr. Genomics
, vol.9
, pp. 208-211
-
-
Ma, C.-X.1
-
22
-
-
57749101107
-
Using spline-enhanced ordinary differential equations for PK/PD model development
-
Wang Y., et al. Using spline-enhanced ordinary differential equations for PK/PD model development. J. Pharmacokinet. Pharmacodyn. 2008, 35:553-571.
-
(2008)
J. Pharmacokinet. Pharmacodyn.
, vol.35
, pp. 553-571
-
-
Wang, Y.1
-
23
-
-
77952292257
-
A differential equation model for functional mapping of a virus-cell dynamic system
-
Luo, et al. A differential equation model for functional mapping of a virus-cell dynamic system. J. Math. Biol. 2010, 61:1-15.
-
(2010)
J. Math. Biol.
, vol.61
, pp. 1-15
-
-
Luo1
-
24
-
-
33845553912
-
Drug interactions, modeling, and simulations
-
Wosilait W.D., Luecke R.H. Drug interactions, modeling, and simulations. I &EC Product Res. Develop. 1982, 21:432-437.
-
(1982)
I &EC Product Res. Develop.
, vol.21
, pp. 432-437
-
-
Wosilait, W.D.1
Luecke, R.H.2
-
25
-
-
0035988625
-
Molecular diagnostics as a predictive tool: genetics of drug efficacy and toxicity
-
Johnson J.A., Evans W.E. Molecular diagnostics as a predictive tool: genetics of drug efficacy and toxicity. Trends Mol. Med. 2002, 8:300-305.
-
(2002)
Trends Mol. Med.
, vol.8
, pp. 300-305
-
-
Johnson, J.A.1
Evans, W.E.2
-
26
-
-
35148831322
-
Modeling oxaliplatin drug delivery to circadian rhythms in drug metabolism and host tolerance
-
Clairambault J. Modeling oxaliplatin drug delivery to circadian rhythms in drug metabolism and host tolerance. Adv. Drug Deliv. Rev. 2007, 59:1054-1068.
-
(2007)
Adv. Drug Deliv. Rev.
, vol.59
, pp. 1054-1068
-
-
Clairambault, J.1
-
27
-
-
72449164580
-
Circadian timing in cancer treatments
-
Lévi F., et al. Circadian timing in cancer treatments. Annu. Rev. Pharmacol. Toxicol. 2010, 50:377-421.
-
(2010)
Annu. Rev. Pharmacol. Toxicol.
, vol.50
, pp. 377-421
-
-
Lévi, F.1
-
28
-
-
33847075354
-
Circadian rhythms: mechanisms and therapeutic implications
-
Lévi F., Schibler U. Circadian rhythms: mechanisms and therapeutic implications. Annu. Rev. Pharmacol. Toxicol. 2007, 47:593-628.
-
(2007)
Annu. Rev. Pharmacol. Toxicol.
, vol.47
, pp. 593-628
-
-
Lévi, F.1
Schibler, U.2
-
29
-
-
77949503379
-
The role of clock genes in pharmacology
-
Paschos G.K., et al. The role of clock genes in pharmacology. Annu. Rev. Pharmacol. Toxicol. 2010, 50:187-214.
-
(2010)
Annu. Rev. Pharmacol. Toxicol.
, vol.50
, pp. 187-214
-
-
Paschos, G.K.1
-
31
-
-
0035106940
-
Changing the dosing schedule minimizes the disruptive effects of interferon on clock function
-
Ohdo S., et al. Changing the dosing schedule minimizes the disruptive effects of interferon on clock function. Nat. Med. 2001, 7:356-360.
-
(2001)
Nat. Med.
, vol.7
, pp. 356-360
-
-
Ohdo, S.1
-
32
-
-
0026235914
-
Biological rhythms in the absorption, distribution, metabolism and excretion of drugs
-
Labrecque G., Bélanger P.M. Biological rhythms in the absorption, distribution, metabolism and excretion of drugs. Pharmacol. Ther. 1991, 52:95-107.
-
(1991)
Pharmacol. Ther.
, vol.52
, pp. 95-107
-
-
Labrecque, G.1
Bélanger, P.M.2
-
33
-
-
0033593306
-
Molecular bases for circadian clocks
-
Dunlap J.C. Molecular bases for circadian clocks. Cell 1999, 96:271-290.
-
(1999)
Cell
, vol.96
, pp. 271-290
-
-
Dunlap, J.C.1
-
34
-
-
0035458732
-
Time zones: a comparative genetics of circadian clocks
-
Young M.W., Kay S.A. Time zones: a comparative genetics of circadian clocks. Nat. Rev. Genet. 2001, 2:702-715.
-
(2001)
Nat. Rev. Genet.
, vol.2
, pp. 702-715
-
-
Young, M.W.1
Kay, S.A.2
-
35
-
-
0037079015
-
Computational approaches to cellular rhythms
-
Goldbeter A. Computational approaches to cellular rhythms. Nature 2002, 420:238-245.
-
(2002)
Nature
, vol.420
, pp. 238-245
-
-
Goldbeter, A.1
-
36
-
-
10844239981
-
A unifying statistical model for QTL mapping of genotype×sex interaction for developmental trajectories
-
Zhao W., et al. A unifying statistical model for QTL mapping of genotype×sex interaction for developmental trajectories. Physiol. Genomics 2004, 19:218-227.
-
(2004)
Physiol. Genomics
, vol.19
, pp. 218-227
-
-
Zhao, W.1
-
37
-
-
10844256588
-
A unified statistical model for functional mapping of environment-dependent genetic expression and genotype×environment interactions for ontogenetic development
-
Zhao W., et al. A unified statistical model for functional mapping of environment-dependent genetic expression and genotype×environment interactions for ontogenetic development. Genetics 2004, 168:1751-1762.
-
(2004)
Genetics
, vol.168
, pp. 1751-1762
-
-
Zhao, W.1
-
38
-
-
0035775486
-
Pharmacogenomics: the inherited basis for interindividual differences in drug response
-
Evans W.E., Johnson J.A. Pharmacogenomics: the inherited basis for interindividual differences in drug response. Annu. Rev. Genomics Hum. Genet. 2001, 2:9-39.
-
(2001)
Annu. Rev. Genomics Hum. Genet.
, vol.2
, pp. 9-39
-
-
Evans, W.E.1
Johnson, J.A.2
-
39
-
-
0037421590
-
Pharmacogenomics - Drug disposition, drug targets, and side effects
-
Evans W.E., McLeod H.L. Pharmacogenomics - Drug disposition, drug targets, and side effects. N. Engl. J. Med. 2003, 348:538-549.
-
(2003)
N. Engl. J. Med.
, vol.348
, pp. 538-549
-
-
Evans, W.E.1
McLeod, H.L.2
-
40
-
-
0242348747
-
Pharmacogenetics: potential for individualized drug therapy through genetics
-
Johnson J.A. Pharmacogenetics: potential for individualized drug therapy through genetics. Trends Genet. 2003, 19:660-666.
-
(2003)
Trends Genet.
, vol.19
, pp. 660-666
-
-
Johnson, J.A.1
-
41
-
-
0037421584
-
Inheritance and drug response
-
Weinshilboum R. Inheritance and drug response. N. Engl. J. Med. 2003, 348:529-537.
-
(2003)
N. Engl. J. Med.
, vol.348
, pp. 529-537
-
-
Weinshilboum, R.1
-
42
-
-
58149352685
-
Pharmacogenomics: candidate gene identification, functional validation and mechanisms
-
Wang L., Weinshilboum R.M. Pharmacogenomics: candidate gene identification, functional validation and mechanisms. Hum. Mol. Genet. 2008, 17:R174-R179.
-
(2008)
Hum. Mol. Genet.
, vol.17
-
-
Wang, L.1
Weinshilboum, R.M.2
-
43
-
-
0035805255
-
Integrated genomic and proteomic analyses of a systematically perturbed metabolic network
-
Ideker T., et al. Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. Science 2001, 292:929-934.
-
(2001)
Science
, vol.292
, pp. 929-934
-
-
Ideker, T.1
-
44
-
-
0036500993
-
Systems biology: a brief overview
-
Kitano H. Systems biology: a brief overview. Science 2002, 295:1662-1664.
-
(2002)
Science
, vol.295
, pp. 1662-1664
-
-
Kitano, H.1
-
45
-
-
33750204290
-
Genetics of global gene expression
-
Rockman M.V., Kruglyak L. Genetics of global gene expression. Nat. Rev. Genet. 2006, 7:862-872.
-
(2006)
Nat. Rev. Genet.
, vol.7
, pp. 862-872
-
-
Rockman, M.V.1
Kruglyak, L.2
-
46
-
-
62549110855
-
Personalizing medicine: a systems biology perspective
-
Deisboeck T.S. Personalizing medicine: a systems biology perspective. Mol. Syst. Biol. 2009, 5:249.
-
(2009)
Mol. Syst. Biol.
, vol.5
, pp. 249
-
-
Deisboeck, T.S.1
-
48
-
-
28044473632
-
Structured antedependence models for functional mapping of multiple longitudinal traits
-
4, Article 33
-
Zhao, W. et al. (2005) Structured antedependence models for functional mapping of multiple longitudinal traits. Stat. Appl. Genet. Mol. Biol. 4, Article 33.
-
(2005)
Stat. Appl. Genet. Mol. Biol.
-
-
Zhao, W.1
|